LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting

By LabMedica International staff writers
Posted on 24 Mar 2023
Print article
Image: The Genomadix Cube can go places where access to diagnostic testing may have previously been limited (Photo courtesy of Genomadix)
Image: The Genomadix Cube can go places where access to diagnostic testing may have previously been limited (Photo courtesy of Genomadix)

Conventional laboratory-based tests may require several days or weeks to generate results. Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour, making results more accessible.

The Genomadix Cube from Genomadix (Ottawa, Canada) is a portable molecular analyzer that employs the gold standard Polymerase Chain Reaction (PCR) technique, delivering accurate outcomes without the need for a full-service laboratory. This decentralized testing option is particularly useful for remote industries and communities where access to a complete lab is limited. The PCR molecular diagnostic instrument generates top-quality results outside of a lab setting and is capable of testing for genetic, infectious disease, and environmental targets on a sample-to-result platform.

Collected samples are placed into a disposable DNA test cartridge, which is then inserted into the analyzer. Once inside, the cartridge extracts the DNA/RNA and produces millions of copies using the PCR process. An optical system detects the amplified fluorescence, and algorithms automatically generate a test outcome. The analyzer's portability, user-friendliness, and real-time processing capabilities allow for the swift generation of critical results.

Related Links:
Genomadix 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more